Russia’s Enteromix cancer vaccine, developed using mRNA technology, has shown 100 percent efficacy in early trials. Not yet approved for clinical use, it offers a personalised approach to training the immune system to target cancer cells
  • vacuumflowerEnglish
    3·
    6 个月前

    With Covid vaccines it wasn’t like this. And I should remind you of Theranos and its backers.